Your browser doesn't support javascript.
loading
Lenvatinib plus pembrolizumab for systemic therapy-naïve and -experienced unresectable hepatocellular carcinoma.
Wu, Chi-Jung; Lee, Pei-Chang; Hung, Ya-Wen; Lee, Chieh-Ju; Chi, Chen-Ta; Lee, I-Cheng; Hou, Ming-Chih; Huang, Yi-Hsiang.
Affiliation
  • Wu CJ; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, 201 Shih-Pai Road, Sec. 2, Taipei, 11217, Taiwan.
  • Lee PC; Institute of Clinical Medicine, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan.
  • Hung YW; Faculty of Medicine, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan.
  • Lee CJ; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, 201 Shih-Pai Road, Sec. 2, Taipei, 11217, Taiwan.
  • Chi CT; Faculty of Medicine, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan.
  • Lee IC; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, 201 Shih-Pai Road, Sec. 2, Taipei, 11217, Taiwan.
  • Hou MC; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, 201 Shih-Pai Road, Sec. 2, Taipei, 11217, Taiwan.
  • Huang YH; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, 201 Shih-Pai Road, Sec. 2, Taipei, 11217, Taiwan.
Cancer Immunol Immunother ; 71(11): 2631-2643, 2022 Nov.
Article in En | MEDLINE | ID: mdl-35347395

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Limits: Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Limits: Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2022 Document type: Article Affiliation country: Country of publication: